8LV Stock Overview
Engages in the production of lithium chemicals products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Arcadium Lithium plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.57 |
| 52 Week High | US$16.57 |
| 52 Week Low | US$12.07 |
| Beta | 1.76 |
| 11 Month Change | 33.91% |
| 3 Month Change | 4.08% |
| 1 Year Change | -8.47% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -34.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8LV | BG Chemicals | BG Market | |
|---|---|---|---|
| 7D | 7.0% | -0.8% | 0.06% |
| 1Y | -8.5% | -2.3% | 10.2% |
Return vs Industry: 8LV underperformed the BG Chemicals industry which returned 1.1% over the past year.
Return vs Market: 8LV underperformed the BG Market which returned 9.1% over the past year.
Price Volatility
| 8LV volatility | |
|---|---|
| 8LV Average Weekly Movement | 12.5% |
| Chemicals Industry Average Movement | 4.4% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in BG Market | 8.2% |
| 10% least volatile stocks in BG Market | 2.6% |
Stable Share Price: 8LV's share price has been volatile over the past 3 months.
Volatility Over Time: 8LV's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of BG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 1,350 | Paul Graves | arcadiumlithium.com |
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds.
Arcadium Lithium plc Fundamentals Summary
| 8LV fundamental statistics | |
|---|---|
| Market cap | €2.71b |
| Earnings (TTM) | €342.69m |
| Revenue (TTM) | €840.60m |
7.9x
P/E Ratio3.2x
P/S RatioIs 8LV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8LV income statement (TTM) | |
|---|---|
| Revenue | US$920.10m |
| Cost of Revenue | US$380.00m |
| Gross Profit | US$540.10m |
| Other Expenses | US$165.00m |
| Earnings | US$375.10m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.08 |
| Gross Margin | 58.70% |
| Net Profit Margin | 40.77% |
| Debt/Equity Ratio | 14.0% |
How did 8LV perform over the long term?
See historical performance and comparison